| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2005 | CN1625405A Combinations comprising cox-2 inhibitors and aspirin |
| 06/08/2005 | CN1625404A Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions |
| 06/08/2005 | CN1625403A Remedies for glaucoma comprising bunazosin and prostaglandins |
| 06/08/2005 | CN1625402A Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2, 3-D)-pyrimidine for treating of urinary incontinence |
| 06/08/2005 | CN1625401A Non-sedating barbituric acid derivatives |
| 06/08/2005 | CN1625400A 2, 4-pyrimidinediamine compounds and their uses |
| 06/08/2005 | CN1625399A Pharmaceutical composition for regeneration of cirrhotic liver |
| 06/08/2005 | CN1625398A A combination treatment for acute myocardial infarction |
| 06/08/2005 | CN1625397A Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
| 06/08/2005 | CN1625396A Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases |
| 06/08/2005 | CN1625395A Lutein/zeaxanthin for glare protection |
| 06/08/2005 | CN1625394A Processes for preparing crystalline and amorphous mupirocin calcium |
| 06/08/2005 | CN1625393A Alpha 2 delta ligands to treat tinnitus |
| 06/08/2005 | CN1625392A Composition for inhalation |
| 06/08/2005 | CN1625390A Multi-stage oral drug controlled-release system |
| 06/08/2005 | CN1625389A Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 06/08/2005 | CN1625387A Cosmetic or dermatological use of vitamin A or the esters thereof in combination with a partly methylated beta-cyclodextrin |
| 06/08/2005 | CN1625385A Lipase inhibiting composition |
| 06/08/2005 | CN1625384A Topical dapsone for the treatment of acne |
| 06/08/2005 | CN1625346A Powder of amino acids and method for producing the same |
| 06/08/2005 | CN1625338A Method for reducing calcified plaque buildup and cellular malfunction and for balancing ionic calcium |
| 06/08/2005 | CN1624948A Method of doping organic semiconductors with quinonediimine derivatives |
| 06/08/2005 | CN1624126A Ret ligand (retl) for stimulating neural and renal growth |
| 06/08/2005 | CN1624003A Carboxymethyl chitosan potassium zinc bismuth and preparation process and application thereof |
| 06/08/2005 | CN1624001A Method for preparing pumpkin polysaccharide |
| 06/08/2005 | CN1623994A New compound |
| 06/08/2005 | CN1623993A Cantharides amine and demethyl cantharides amine derivative and application in medicine thereof |
| 06/08/2005 | CN1623992A Novel medicine of non peptide like angiotensin II receptor antagonism agent, their preparation and application |
| 06/08/2005 | CN1623987A Novel processes for preparing torsemide |
| 06/08/2005 | CN1623985A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 06/08/2005 | CN1623984A Fused-ring compounds and use thereof as drugs |
| 06/08/2005 | CN1623561A Antiadhesion protective preparation and its application |
| 06/08/2005 | CN1623560A Preparation method of antiadhesion protective preparation |
| 06/08/2005 | CN1623559A Anti adhesion protective preparation |
| 06/08/2005 | CN1623558A 南瓜多糖肠溶制剂 Pumpkin polysaccharide enteric preparation |
| 06/08/2005 | CN1623557A Application of gold ear mycelium polysaccharide for lowering blood fat and blood sugar |
| 06/08/2005 | CN1623556A Anticance auxiliary medicine using proto ginseng triol as effective component and its application |
| 06/08/2005 | CN1623555A Notoginseng saponin drops |
| 06/08/2005 | CN1623554A Anticancer auxiliary medicine using C-K as effective component and its application |
| 06/08/2005 | CN1623553A Anticancer auxiliary medicine using 20 (S)-panaxcoside Rg3 as effertive component and its application |
| 06/08/2005 | CN1623552A Injection preparation containing active component adefuwei or its salt and its preparation method |
| 06/08/2005 | CN1623551A Solid dispersion containing active component adefuwei or its salt and its preparation method |
| 06/08/2005 | CN1623550A Hydroxy progesterone caproate oral preparation and its use |
| 06/08/2005 | CN1623549A Eyedrops |
| 06/08/2005 | CN1623548A Galanthamine slow release preparation and its preparation method |
| 06/08/2005 | CN1623547A Medical use of artificial lywrine |
| 06/08/2005 | CN1623546A Compound preparation for treating acne |
| 06/08/2005 | CN1623545A Glasqiong hydrochloride oral disintegrating tablet and its preparation method |
| 06/08/2005 | CN1623544A Preparation of injection amoxicillin subaton |
| 06/08/2005 | CN1623543A Organic compounds |
| 06/08/2005 | CN1623542A Butyl benzene phthalein soft capsule and its preparation method |
| 06/08/2005 | CN1623541A Application of aloelactone in preparation of medicine |
| 06/08/2005 | CN1623540A Unit dose form cantharide acid freeze-dried powder injection preparation and its preparation method |
| 06/08/2005 | CN1623539A Milk thistle silybum marianum long effect preparation and its preparation method |
| 06/08/2005 | CN1623538A Tanshinone II A sulfonic acid or tanshinone II A sodium sulfonate freeze-dried powder injection and its preparation method |
| 06/08/2005 | CN1623536A Preparation technology of isosorbide dinitrate injection |
| 06/08/2005 | CN1623535A Medicinal composition for treating bleeding disease and its use |
| 06/08/2005 | CN1623534A Use of creatine |
| 06/08/2005 | CN1623533A Drug formulation with controlled release of active ingredient |
| 06/08/2005 | CN1205248C Biodegradable poly(alkylene oxide)-poly cp-dioxanone) block polymer soluble in organic solvents, and drug delivery composition comprising same |
| 06/08/2005 | CN1205231C Water soluble heteropolysaccharide with anti-tumor activity and its preparing method and use |
| 06/08/2005 | CN1205219C Unsaturated 14,15-cyclopropane-cendrostanes, a method for their production and pharmaceutical compositions containing these compounds |
| 06/08/2005 | CN1205216C Safflower lyochrome rich in carthamin A, its preparing process, its preparation containing them and its medical usage |
| 06/08/2005 | CN1205213C Method for the production of imidazol-[1,2-c][2,3]-benzodiazepines and intermediates in production thereof |
| 06/08/2005 | CN1205211C Pleuromutilin derivatives as antimicrobials |
| 06/08/2005 | CN1205210C 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 06/08/2005 | CN1205208C C-21 modified epothilones |
| 06/08/2005 | CN1205207C Substituted indolealkanoic acids |
| 06/08/2005 | CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 06/08/2005 | CN1205193C Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide |
| 06/08/2005 | CN1205191C Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 06/08/2005 | CN1205188C 4,5-dihydro-1h-pyrazole derivatives having CB1-antagonistic activity |
| 06/08/2005 | CN1205187C New amidino derivatives and their use as thrombin inhibitors |
| 06/08/2005 | CN1205186C ACE inhibitor nitric salts |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/08/2005 | CN1205184C Beta-lactan |
| 06/08/2005 | CN1205183C New amidino derivatives and their use as thrombin inhibitors |
| 06/08/2005 | CN1205181C Matrix metalloproteinase inhibitors |
| 06/08/2005 | CN1205176C Stable salts of o-acetylsalicyclic with basic amino acids |
| 06/08/2005 | CN1205175C Application of amine derivative in medicine prepared with the function of anti-pulmonary hypertension |
| 06/08/2005 | CN1205172C Crystals of sodium salt of pravastatin |
| 06/08/2005 | CN1205166C Synthesis of antitumour medicine 4-[1-(3,5,8,8-petamethyl-5,6,7,8-tetrahydro-2-naphthyl) ethenyl] benzoic acid |
| 06/08/2005 | CN1204924C Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 06/08/2005 | CN1204923C Anhydrous topical ski preparation |
| 06/08/2005 | CN1204917C Complex rhizoma paridis tincture and preparing method thereof |
| 06/08/2005 | CN1204912C External medicine for treating burn and scald, soft tissue injury and skin disease |
| 06/08/2005 | CN1204909C Ointment made of Chinese medicine herbs for treating refractory bedsore |
| 06/08/2005 | CN1204907C Chinese medicine composite external liniment for treating alopecia areata |
| 06/08/2005 | CN1204897C Licorice polysaccharide powder-injection |
| 06/08/2005 | CN1204896C Preparation method and use of ribonucleic acid injection |
| 06/08/2005 | CN1204895C Etoposide enteric slow (controlled) release solid dispersing preparation and its preparation method |
| 06/08/2005 | CN1204894C Anticancer application of 2-methoxy estradiol, Neomycin sulfate and their mixture |
| 06/08/2005 | CN1204893C Pharmaceutical composition |
| 06/08/2005 | CN1204892C Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 06/08/2005 | CN1204891C Injection containing tramadol and its application |
| 06/08/2005 | CN1204890C Method for preventing abuse of opioid dosage forms |
| 06/08/2005 | CN1204889C Adhesion receptor antagonists |
| 06/08/2005 | CN1204888C Usage of indole derivatives for treating tumours |
| 06/08/2005 | CN1204887C Green tea polyphenol anti-caries coating film |
| 06/08/2005 | CN1204886C Condensation derivatives of thiocolchicine and baccatin and its composition |